scispace - formally typeset
R

Riccardo Dalla-Favera

Researcher at New York University

Publications -  58
Citations -  5147

Riccardo Dalla-Favera is an academic researcher from New York University. The author has contributed to research in topics: Lymphoma & Gene. The author has an hindex of 33, co-authored 58 publications receiving 5115 citations. Previous affiliations of Riccardo Dalla-Favera include Harvard University & Columbia University.

Papers
More filters
Journal ArticleDOI

Expression of cellular homologues of retroviral onc genes in human hematopoietic cells

TL;DR: Total cellular poly(A)-enriched RNA from a variety of fresh human leukemic blood cells and hematopoietic cell lines was analyzed for homology with molecularly cloned DNA probes containing the onc sequence of Abelson murine leukemia virus (Ab-MuLV), Harvey murine sarcoma virus (Ha-MuSV), simian sarcomA virus (SSV), and avian myelocytomatosis virus strain MC29.
Journal ArticleDOI

Lymphoid Neoplasia Associated with the Acquired Immunodeficiency Syndrome (AIDS): The New York University Medical Center Experience with 105 Patients (1981-1986)

TL;DR: This article identified 105 patients with lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS) at the New York University Medical Center from 1981 through 1986: 89 had non-Hodgkin lymphoma; 13, Hodgkin disease; and 3, chronic lymphocytic leukemia.
Journal ArticleDOI

Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma

TL;DR: Different genetic mechanisms may be involved in chromosomal translocation/c-myc activation, and these differences may be a function of differences in the stage of differentiation of eBL versus sBL.
Journal ArticleDOI

Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29).

TL;DR: Restriction mapping experiments and heteroduplex analysis show that c-myc sequences of this locus are interrupted by one intron, suggesting that lambda-LMC-12 and -41 contain the complete functional c- myc gene.
Journal ArticleDOI

Pathogenesis of Burkitt lymphoma: Expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts

TL;DR: EBV infection and c-myc activation are sufficient for the tumorigenic conversion of human B cells in vitro, strongly supporting the hypothesis that these same two pathogenetic steps may be involved in the in vivo development of Burkitt lymphoma.